Zdrowie i gospodarka · 09/04/2018
FDA Releases Draft Guidance on Pediatric Studies for Atopic Dermatitis Treatments
The FDA has released a draft guidance outlining its recommendations for when pediatric patients should be included in the development of systemic drugs for atopic dermatitis, a condition that affects the skin.
Source: Federal Register — Food and Drug AdministrationOpen original release →